Savara (SVRA) closed at $4.64 on November 13, 2026, down 1.7% from the previous close, on volume of 3,029,512 shares (30-day average 2,594,086).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 12, 2026 | Call Butterfly | 18-Dec-265 : 7[2x] : 9 C | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
Savara Announces New Employment Inducement Grant
Business Wire (Thu, 12-Nov 4:05 PM ET)
Oppenheimer Remains a Buy on Savara (SVRA)
TipRanks (Wed, 11-Nov 8:36 AM ET)
Business Wire (Wed, 21-Oct 1:10 PM ET)
Business Wire (Mon, 12-Oct 4:05 PM ET)
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Savara trades on the NASDAQ stock market under the symbol SVRA.
As of November 13, 2026, SVRA stock price declined to $4.64 with 3,029,512 million shares trading.
SVRA has a beta of 1.04, meaning it tends to be more sensitive to market movements. SVRA has a correlation of 0.06 to the broad based SPY ETF.
SVRA has a market cap of $1.02 billion. This is considered a Small Cap stock.
Last quarter Savara reported $0 in Revenue and -$.17 earnings per share. This fell short of revenue expectation by $-1 million and met earnings estimates .
In the last 3 years, SVRA traded as high as $7.01 and as low as $1.89.
The top ETF exchange traded funds that SVRA belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWO.
SVRA has underperformed the market in the last year with a price return of +8.9% while the SPY ETF gained +13.4%. SVRA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.0% and -3.7%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
SVRA support price is $4.50 and resistance is $4.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SVRA shares will trade within this expected range on the day.
